top of page

Hundreds of Studies Show COVID-19 Jabs Cause Harm

By LifeSite News February 18, 2022

LifeSite News has posted an article linking to hundreds of studies showing that the COVID jabs indeed pose dangers. See some of the links to these studies below:

Cerebral venous thrombosis after COVID-19 vaccination in the UK: a multicentre cohort study:

Fatal cerebral hemorrhage after COVID-19 vaccine:

Myocarditis after mRNA vaccination against SARS-CoV-2, a case series:

Three cases of acute venous thromboembolism in women after vaccination against COVID-19:

Acute thrombosis of the coronary tree after vaccination against COVID-19:

US case reports of cerebral venous sinus thrombosis with thrombocytopenia after vaccination with Ad26.COV2.S (against covid-19), March 2 to April 21, 2020:

Portal vein thrombosis associated with ChAdOx1 nCov-19 vaccine:

Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): position statement of the Italian Society for the Study of Hemostasis and Thrombosis (SISET):

Vaccine-induced immune immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination with COVID-19; a systematic review:

Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines:

Covid-19 vaccine-induced thrombosis and thrombocytopenia: a commentary on an important and practical clinical dilemma:

Thrombosis with thrombocytopenia syndrome associated with COVID-19 viral vector vaccines:

COVID-19 vaccine-induced immune-immune thrombotic thrombocytopenia: an emerging cause of splanchnic vein thrombosis:

The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic immune thrombocytopenia (covid):

Roots of autoimmunity of thrombotic events after COVID-19 vaccination:

Cerebral venous sinus thrombosis after vaccination: the United Kingdom experience:

Thrombotic immune thrombocytopenia induced by SARS-CoV-2 vaccine:

Myocarditis after immunization with COVID-19 mRNA vaccines in members of the US military. This article reports that in “23 male patients, including 22 previously healthy military members, myocarditis was identified within 4 days after receipt of the vaccine”:

Thrombosis and thrombocytopenia after vaccination with ChAdOx1 nCoV-19:

Association of myocarditis with the BNT162b2 messenger RNA COVID-19 vaccine in a case series of children:

Thrombotic thrombocytopenia after vaccination with ChAdOx1 nCov-19:

Post-mortem findings in vaccine-induced thrombotic thrombocytopenia (covid-19):

Thrombocytopenia, including immune thrombocytopenia after receiving COVID-19 mRNA vaccines reported to the Vaccine Adverse Event Reporting System (VAERS):

Acute symptomatic myocarditis in seven adolescents after Pfizer-BioNTech COVID-19 vaccination:

Aphasia seven days after the second dose of an mRNA-based SARS-CoV-2 vaccine. Brain MRI revealed an intracerebral hemorrhage (ICBH) in the left temporal lobe in a 52-year-old man.

Comparison of vaccine-induced thrombotic episodes between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines:

Hypothesis behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination:

Blood clots and bleeding episodes after BNT162b2 and ChAdOx1 nCoV-19 vaccination: analysis of European data:

Cerebral venous thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine:

Primary adrenal insufficiency associated with thrombotic immune thrombocytopenia induced by the Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine (VITT):

Myocarditis and pericarditis after vaccination with COVID-19 mRNA: practical considerations for care providers:

“Portal vein thrombosis occurring after the first dose of SARS-CoV-2 mRNA vaccine tion with COVID-19: a case report:

Guillain-Barré syndrome after the first injection of ChAdOx1 nCoV-19 vaccine: first report:

SARS-CoV-2 vaccines are not safe for those with Guillain-Barre syndrome following vaccination:

Acute hyperactive encephalopathy following COVID-19 vaccination with dramatic response to methylprednisolone: a case report:

Facial nerve palsy following administration of COVID-19 mRNA vaccines: analysis of self-report database:

Neurological symptoms and neuroimaging alterations related to COVID-19 vaccine: cause or coincidence:

New-onset refractory status epilepticus after ChAdOx1 nCoV-19 vaccination:

Acute myelitis and ChAdOx1 nCoV-19 vaccine: coincidental or causal association:

Bell’s palsy and SARS-CoV-2 vaccines: an unfolding story:

Bell’s palsy after the second dose of the Pfizer COVID-19 vaccine in a patient with a history of recurrent Bell’s palsy:

Acute-onset central serous retinopathy after immunization with COVID-19 mRNA vaccine:.

Bell’s palsy after COVID-19 vaccination: case report:

An academic hospital experience assessing the risk of COVID-19 mRNA vaccine using patient’s allergy history: